2. Lin WR, Lai RS. Pulmonary lymphangitic carcinomatosis. QJM, 2014, 107(11): 935-936.
[2]
7. Charest M, Armanious S. Prognostic implication of the lymphangitic carcinomatosis pattern on perfusion lung scan. Can Assoc Radiol J, 2012, 63(4): 294-303.
[3]
1. Bruce DM, Heys SD, Eremin O. Lymphangitis carcinomatosa: a literature review. J R Coll Surg Edinb, 1996, 41(1): 7-13.
[4]
3. Khachekian A, Shargh S, Arabian S. Pulmonary lymphangitic carcinomatosis from metastatic gastric adenocarcinoma: case report. J Am Osteopath Assoc, 2015, 115(5): 332-337.
5. Pernot S, Voron T, Perkins G, et al. Signet-ring cell carcinoma of the stomach: impact on prognosis and specific therapeutic challenge. World J Gastroenterol, 2015, 21(40): 11428-11438.
[7]
6. Lee SH, Jee SR, Kim JH, et al. Intramucosal gastric cancer: the rate of lymph node metastasis in signet ring cell carcinoma is as low as that in well-differentiated adenocarcinoma. Eur J Gastroenterol Hepatol, 2015, 27(2): 170-174.
[8]
8. Ikezoe J, Godwin JD, Hunt KJ, et al. Pulmonary lymphangitic carcinomatosis: chronicity of radiographic findings in long-term survivors. Am J Roentgenol, 1995, 165(1): 49-52.
[9]
9. Prakash P, Kalra MK, Sharma A, et al. FDG PET/CT in assessment of pulmonary lymphangitic carcinomatosis. Am J Roentgenol, 2010, 194(1): 231-236.
[10]
10. Piessen G, Messager M, Leteurtre E, et al. Signet ring cell histology is an independent predictor of poor prognosis in gastric adenocarcinoma regardless of tumoral clinical presentation. Ann Surg, 2009, 250(6): 878-887.
